iCell Cardiomyocytes — highly purified in the quantities you need.
Applications include targeted drug discovery, toxicity testing, and other life science research…
Check out our new training video:
Handling iCell Cardiomyocytes!
Check out our Product Pipeline to learn how CDI is pushing discovery with development of new iPSC-derived cell types!
Learn more about iPS 2.0™: CDI's induced, pluripotent stem (iPS) stem cell technology that coaxes the full potential from adult tissue or blood cells to generate a range of unique, terminally differentiated cells lines for in vitro research and drug discovery applications.
NEW!
Handling iCell Cardiomyocytes
June 29, 2010
PLoS One:
Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes
June 2010
Drug Discovery:
Induced Pluripotent Stem Cells - A New Wave of Tools for Drug Discovery
June 15, 2010
Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity
Cellular Dynamics is the world’s largest producer of fully functional human cells derived from induced pluripotent stem (iPS) cells. In a field only a few decades old, CDI scientists tout more than 285 years combined of stem cell experience. Building on this expertise, our iCell™ products provide industrialized quantities of terminally differentiated human cells enabling basic research, efficient drug discovery programs, and reliably predictive toxicity and efficacy screening through in vitro clinical trials.